Karyopharm Therapeutics I... (KPTI)
NASDAQ: KPTI
· Real-Time Price · USD
5.65
-0.27 (-4.56%)
At close: Aug 18, 2025, 3:59 PM
5.66
0.09%
After-hours: Aug 18, 2025, 07:13 PM EDT
Karyopharm Therapeutics Revenue
Karyopharm Therapeutics reported an annual revenue of $145.24M, reflecting a -0.55% growth. For the quarter ending June 30, 2025, Karyopharm Therapeutics generated $37.93M in revenue.
Revenue (ttm)
145.24M
Revenue Growth
-0.55%
Price / Sales Ratio
0.57
Revenue / Employee
520.56K
Employees
279
Market Cap
48.99M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 145.24M | -0.55% |
| Dec 31, 2023 | 146.03M | -7.03% |
| Dec 31, 2022 | 157.07M | -25.14% |
| Dec 31, 2021 | 209.82M | +94.12% |
| Dec 31, 2020 | 108.08M | +164.31% |
| Dec 31, 2019 | 40.89M | +34.80% |
| Dec 31, 2018 | 30.34M | +1790.09% |
| Dec 31, 2017 | 1.6M | +942.21% |
| Dec 31, 2016 | 154K | -38.40% |
| Dec 31, 2015 | 250K | +9.17% |
| Dec 31, 2014 | 229K | -40.83% |
| Dec 31, 2013 | 387K | -38.96% |
| Dec 31, 2012 | 634K | +317.11% |
| Dec 31, 2011 | 152K | n/a |